首页> 外文期刊>Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association >Combination of Curcumin (an Active Ingredient of Curcuma Longa) and Mesalamine Versus Mesalamine Alone in the Treatment of Mild to Moderate Ulcerative Colitis A Proposal for a Multicenter Prospective Study: Amendment 1 (19.6.2011)

【24h】

Combination of Curcumin (an Active Ingredient of Curcuma Longa) and Mesalamine Versus Mesalamine Alone in the Treatment of Mild to Moderate Ulcerative Colitis A Proposal for a Multicenter Prospective Study: Amendment 1 (19.6.2011)

机译：姜黄素（姜黄素的有效成分）与美沙拉敏与单独使用美沙拉敏的组合治疗轻度至中度溃疡性结肠炎的多中心前瞻性研究建议：修订案1（19.6.2011）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association》 |2016年第6期|共2页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献

1. Combination of Curcumin (an Active Ingredient of Curcuma Longa) and Mesalamine Versus Mesalamine Alone in the Treatment of Mild to Moderate Ulcerative Colitis A Proposal for a Multicenter Prospective Study: Amendment 1 (19.6.2011) [J] . Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association . 2016,第6期

机译：姜黄素（姜黄素的有效成分）与美沙拉敏与单独使用美沙拉敏的组合治疗轻度至中度溃疡性结肠炎的多中心前瞻性研究建议：修订案1（19.6.2011）
2. Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial [J] . Lang Alon, Salomon Nir, Wu Justin C. Y., Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association . 2015,第8期

机译：姜黄素与美沙拉敏联合在轻度至中度溃疡性结肠炎患者中随机对照试验诱导缓解
3. Health-Related Quality of Life and Work-Related Outcomes for Patients With Mild-to-Moderate Ulcerative Colitis and Remission Status Following Short-Term and Long-Term Treatment With Multimatrix Mesalamine: A Prospective, Open-Label Study [J] . Yarlas Aaron, DHaens Geert, Willian Mary Kaye, Inflammatory bowel diseases . 2018,第2期

机译：与Multimatrix Mesalamine短期和长期治疗后患有轻度至中度溃疡性结肠炎和缓解状态的患者的健康状生活质量和与工作相关的结果
4. Clinical study on saccharomyces boulardii in the treatment of patients with mild to moderate ulcerative colitis [C] . Tang Hai-Ying, Wu Hao, Mao Jing-Wei, IEEE International Conference on Control Automation . 2014

机译：布拉氏酵母菌治疗轻度至中度溃疡性结肠炎的临床研究
5. Changes in health-related quality of life and work-related outcomes for patients with mild-to-moderate ulcerative colitis receiving short-term and long-term treatment with multimatrix mesalamine: a prospective open-label study [O] . Mary Kaye Willian, Geert D’Haens, Aaron Yarlas, 2018

机译：接受多基质美沙拉敏短期和长期治疗的轻度至中度溃疡性结肠炎患者的健康相关生活质量和工作相关结局的变化：一项前瞻性开放性研究
6. P389 Efficacy of once a day multi matrix mesalamine formulation, lialda in patients with active mild to moderate ulcerative colitis after inadequate response to the pH-dependent release mesalamine formulation, asacol [O] . N Yoshimura, S Okano, M Sako, 2018

机译：P389疗效每日一次Metrix mesalamine配方，Lialda在患者中有活性轻度至中度溃疡性结肠炎的患者不足反应对pH依赖性释放梅纳胺制剂，asacol

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号